Advertisement

Picture Berlin Partner Top News Aignostics Mayo Clinic Pathology 650x100px
Organisation › Details

ViroLogik GmbH

ViroLogik GmbH deals with the development, testing and marketing of new medications and forms of treatment for viral infections. In so doing, the company uses patented procedures in order to influence the interaction of cellular and viral factors. The innovative therapeutic approaches are used in the treatment of infections with viruses, which, due to their high frequency of mutation, tend to be resistant to the classic treatment forms for viruses [in particular the Human Immunodeficiency Virus (HIV), Influenza-A-Virus (IAV) and Hepatitis-C- and B-Viruses (HB/CV)]. *

 

Period Start 2008-05-28 existent
Product Industry virostatic agent
Person Person Appelmann, Karl (Gentium 201111– Country Manager DE+ AT + CH before ViroLogik 201105 Managing Director)
     
Region Region Erlangen
  Country Germany
  Street 91 Henkestr.
  City 91052 Erlangen
  Tel +49-9131-974434-0
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2024-12-29

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top